Agresti R - Search Results

1

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.

Plantamura I, Casalini P, Dugnani E, Sasso M, D'Ippolito E, Tortoreto M, Cacciatore M, Guarnotta C, Ghirelli C, Barajon I, Bianchi F, Triulzi T, Agresti R, Balsari A, Campiglio M, Tripodo C, Iorio MV, Tagliabue E. Plantamura I, et al. Among authors: agresti r. Mol Oncol. 2014 Jul;8(5):968-81. doi: 10.1016/j.molonc.2014.03.015. Epub 2014 Mar 27. Mol Oncol. 2014. PMID: 24747080 Free PMC article.

2

Proliferation of breast carcinoma during menstrual phases.

Ménard S, Casalini P, Agresti R, Pilotti S, Balsari A. Ménard S, et al. Among authors: agresti r. Lancet. 1998 Jul 11;352(9122):148-9. doi: 10.1016/S0140-6736(98)85058-7. Lancet. 1998. PMID: 9672307 No abstract available.

3

Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

Balsari A, Casalini P, Tagliabue E, Greco M, Pilotti S, Agresti R, Giovanazzi R, Alasio L, Rumio C, Cascinelli N, Colnaghi MI, Ménard S. Balsari A, et al. Among authors: agresti r. Am J Pathol. 1999 Nov;155(5):1543-7. doi: 10.1016/S0002-9440(10)65470-3. Am J Pathol. 1999. PMID: 10550311 Free PMC article.

4

Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis.

Greco M, Agresti R, Cascinelli N, Casalini P, Giovanazzi R, Maucione A, Tomasic G, Ferraris C, Ammatuna M, Pilotti S, Menard S. Greco M, et al. Among authors: agresti r. Ann Surg. 2000 Jul;232(1):1-7. doi: 10.1097/00000658-200007000-00001. Ann Surg. 2000. PMID: 10862188 Free PMC article.

5

Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo.

Ardini E, Agresti R, Tagliabue E, Greco M, Aiello P, Yang LT, Ménard S, Sap J. Ardini E, et al. Among authors: agresti r. Oncogene. 2000 Oct 12;19(43):4979-87. doi: 10.1038/sj.onc.1203869. Oncogene. 2000. PMID: 11042685

6

HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer.

Ménard S, Casalini P, Campiglio M, Pupa S, Agresti R, Tagliabue E. Ménard S, et al. Among authors: agresti r. Ann Oncol. 2001;12 Suppl 1:S15-9. doi: 10.1093/annonc/12.suppl_1.s15. Ann Oncol. 2001. PMID: 11521715 Free article. Review.

7

HER2 as a prognostic factor in breast cancer.

Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A. Ménard S, et al. Among authors: agresti r. Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.

8

The early relapse of premenopausal patients after surgery for node-positive breast carcinoma.

Tagliabue E, Agresti R, Ghirelli C, Morelli D, Ménard S. Tagliabue E, et al. Among authors: agresti r. Breast Cancer Res Treat. 2001 Nov;70(2):155-6. doi: 10.1023/a:1012955229031. Breast Cancer Res Treat. 2001. PMID: 11768606 Corrected and republished. No abstract available.

9

Early relapse of premenopausal patients after surgery for node-positive breast carcinoma.

Tagliabue E, Agresti R, Ghirelli C, Morelli D, Ménard S. Tagliabue E, et al. Among authors: agresti r. Breast Cancer Res Treat. 2002 Mar;72(2):185-6; author reply 186-7. doi: 10.1023/a:1014849328159. Breast Cancer Res Treat. 2002. PMID: 12038709 No abstract available.

10

Role of HER2 in wound-induced breast carcinoma proliferation.

Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, Martel M, Giovanazzi R, Greco M, Balsari A, Ménard S. Tagliabue E, et al. Among authors: agresti r. Lancet. 2003 Aug 16;362(9383):527-33. doi: 10.1016/S0140-6736(03)14112-8. Lancet. 2003. PMID: 12932384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page